Congrats to the InVision Medical Technology Corporation team! Clear identification of etiologies of HF, particularly HFpEF, is critical for early access and targeted treatment!

Strong evidence validated a significant reduction of treatment time from the first randomized controlled trial to evaluate the clinical impact of AI-enabled electrocardiogram on ST-elevation myocardial infarction treatment. Read the full trial results: nejm.ai/4eG7ZwC

I made the closed-source vs. open-weight models figure for this moment.

Editorial by Robert Avram and William Fearon: AI-RISE to the Challenge — Artificial Intelligence Reduces Time to Treatment in STEMI nejm.ai/4bob3dW #AIinMedicine #Cardiology

Only a few days left to submit your research papers on #AI in Clinical Medicine (no deadline extensions)!

Clinical and genetic associations of asymmetric apical and septal left ventricular hypertrophy bit.ly/46HXwNL #EHJDigital #UKBiobank #GWAS Nico Bruining EiC EHJ Digital Health rafavidalperez Gerhard Hindricks HFAPresident

EchoNet-MR is a novel, opensource deep learning algorithm trained on >2 million videos from transthoracic echocardiography for high-throughput mitral regurgitation (MR) assessment Amey Vrudhula @DavidOuyang Cedars-Sinai Academic Medicine Grant Duffy Milos Vukadinovic ahajournals.org/doi/10.1161/CI…

Are you looking for a PhD program in health AI embedded in a top US hospital with access to clinical data & physicians? Check out our new PhD program at Cedars-Sinai Medical Center in LA cedars-sinai.edu/education/grad… #phd #artificialintelligence #Bioinformatics

Great article by Mariana Lenharo highlighting the landscape of medical AI. Was a delight to chat with you and brainstorm about the intersection of deployment, regulation, and reimbursement!

I'm not saying it's the same thing, but there's something beautifully poetic about the fact that the cost of a 24TB hard drive ($439) is less than a single month's rent for 24TB of storage on AWS S3 ($552). Much of the cloud is like this.

Such a fun conversation with Andrew Beam and Arjun (Raj) Manrai! So many friends and interests in common! NEJM AI

🚨­­ MAJOR news in the #ATTR #amyloidosis world! Today the ­­­much-anticipated HELIOS-B results were presented European Society of Cardiology & simultaneously published in NEJM. The largest ATTR-CM trial published to date, testing #vutrisiran vs. placebo. Bottom line: Huge win for vutrisiran!

Strong work lead by chief fellow Rishi K Trivedi, MD PhD!

Congratulations to the HELIOS-B investigators! Early recognition of TTR amyloidosis leads to the most effective treatment of this deadly disease. Initiation of therapy at earlier stages lead to an even more dramatic impact on survival and decrease in cardiovascular events!